Benefits of Empagliflozin in Patients With Heart Failure and Reduced Ejection Fraction Without Diabetes Mellitus

NCT06632561 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: Empagliflozin 10 mg
DRUG: Placebo

Sponsor

Ashraf Wasfy Beshay Aziz